FDA Inspection 1310416 — Sunrise Pharmaceutical, Inc.

Sunrise Pharmaceutical, Inc. — FEI 3004813394

The FDA completed an inspection of Sunrise Pharmaceutical, Inc. on Mar 31, 2026 in Rahway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 31, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rahway, NJ (United States)

Citations

IDCFRDescription
434221 CFR 211.142(b)Storage under appropriate conditions

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.